MiNK Therapeutics, Inc. (INKT)
11.91
-0.27
(-2.22%)
USD |
NASDAQ |
Dec 16, 16:00
12.20
+0.29
(+2.43%)
After-Hours: 17:32
MiNK Therapeutics EPS Diluted (Quarterly): -0.6499 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.888M |
| Total Expenses (Quarterly) | 2.888M |
| Enterprise Value | 48.62M |
| Earnings Yield | -25.48% |
| Normalized Earnings Yield | -24.01 |